The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions.
Airo
Paolo
P
Scarsi
Mirko
M
Malagoli
Alberto
A
Carella
Graziella
G
Izzo
Ilaria
I
Carosi
Giampiero
G
Torti
Carlo
C
D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control*; D005434:Flow Cytometry / Q000191:economics / Q000379:methods*; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology; D015235:HLA-B Antigens / Q000032:analysis* / Q000235:genetics / Q000276:immunology; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D000099227:Abacavir
D015224:Dideoxynucleosides; D015235:HLA-B Antigens; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir; C484830:HLA-B*57:01 antigen